Why we must pass the Medicare Multi-Cancer Early Detection Screening Coverage Act

Cancer News

 Why we must pass the Medicare Multi-Cancer Early Detection Screening Coverage Act
United States Latest News,United States Headlines
  • 📰 amNewYork
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 59%

On the 23rd anniversary of Sept. 11th, an estimated hundreds of thousands of local residents are still grappling with the effects of unprecedented toxic

exposure. This group notably includes first responders as well as the tradesmen and tradeswomen who cleared and rebuilt lower Manhattan. Those impacted face a higher risk for certain types of cancer than the general public, and Congress has the opportunity to help them and others at-risk by passing the Medicare Multi-Cancer Early Detection Screening Coverage Act .

Cancer screening has proven to be an incredibly powerful tool for individuals and communities. Tests such as mammograms and colonoscopies have saved countless lives by helping patients and their doctors pursue earlier diagnoses. But of the more than 100 types of cancers, just five have common screenings: breast, cervical, prostate, a small subset of lung, and colorectal. The remaining unscreened cancers cause more than 70% of cancer deaths in the US.

As a lawmaker representing parts of Manhattan and the leader of New York’s building and construction trades union, we have seen firsthand the impact of unscreened cancer on our constituents. An estimated 91,000 people were exposed to toxic contaminants at Ground Zero because they answered the call to help on 9/11 and in the months and years that followed with recovery, de-construction, and re-construction.

But to realize meaningful change, Congress has to urgently pass the Medicare Multi-Cancer Early Detection Act, to create a coverage pathway within Medicare to cover these cancer tests. Half of new cancer cases every year are among Medicare beneficiaries, and passing this bill is an important first step to make access possible.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

amNewYork /  🏆 336. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shawn Mendes' Smoldering Twitter ComebackShawn Mendes' Smoldering Twitter ComebackWhy, why, why would you post that picture, Shawn?
Read more »

Piaf Kitchen + Wine + Bar Is a Mediterranean Oasis in Downtown GrapevinePiaf Kitchen + Wine + Bar Is a Mediterranean Oasis in Downtown GrapevineMulti-level Piaf is packed on most weekends, so we decided to find out why.
Read more »

– Cancer Immunotherapy - Tampa, Florida job with H. Lee Moffitt Cancer Center & Research Institute– Cancer Immunotherapy - Tampa, Florida job with H. Lee Moffitt Cancer Center & Research InstituteMoffitt Cancer Center and Research Institute is proud to be Florida’s only National Cancer Institute-designated Comprehensive Cancer Center located in Tampa. We strive to be the leader in understanding the complexity of cancer through team science and applying those insights for human benefits.
Read more »

Skin cancer is most common cancer in Channel IslandsSkin cancer is most common cancer in Channel IslandsMalignant skin cancer makes up about 40% of all cases in Jersey and Guernsey, data shows.
Read more »

Targeted cancer cell therapy may slow endometrial cancerTargeted cancer cell therapy may slow endometrial cancerThere may be a way to slow the growth of endometrial cancer using targeted cancer cell therapy to silence the ERBB2 gene expression.
Read more »

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trialExperimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trialInterim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer, melanoma and other solid tumours.
Read more »



Render Time: 2025-02-19 20:09:20